According to the company, the new brand will simplify the development of controlled release products, and offer a streamlined approach to formulation design, while also enhancing manufacturing efficiency.
Colorcon (Harleysville, PA) has consolidated its range of controlled release products under the Corelease Controlled Release Formulated Systems brand. According to the company, the new brand will simplify the development of controlled release products, and offer a streamlined approach to formulation design, while also enhancing manufacturing efficiency. Corelease will initially showcase two Colorcon coatings: Corelease EC Ethylcellulose Organic Coating System designed for the solvent-coating of multiparticulates and tablets for sustained release and flavor masking applications, and Corelease CA Formulated Osmotic Coating System which is a one-step semipermeable membrane designed to ensure consistent release from push-pull osmotic pump (PPOP) tablets.
Colorcon will expand the range during 2024, and bring PPOP direct-to-hopper blends to market to enhance consistency and efficiency of osmotic tablet production. “By consolidating these cutting-edge coatings under the new Corelease brand, we are laying the foundation to bring together our innovative products and expertise to support the evolving needs of the industry for controlled release. Our aim is to enhance productivity, reduce time-to-market, and empower pharmaceutical manufacturers to achieve new levels of efficiency,” said Beth Tran, global business manager, in a press release.
“Our focused development program aims to address industry challenges, particularly in the case of PPOP tablets,” said Ali Rajabi-Siahboomi, PhD, vice president and chief innovation officer. “These dosage forms commonly involve the use of polyethylene oxide (PEO) in their formulation, leading to multiple processing steps and cleaning procedures during manufacturing. Our novel approach will bring simple direct-to-hopper solutions that save time and reduce complexity.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.